PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 490 | +3.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 474 | -92.8% | 0.00% | – |
| Q2 2022 | $12,000 | +500.0% | 6,588 | +808.7% | 0.00% | – |
| Q4 2021 | $2,000 | -98.7% | 725 | -98.2% | 0.00% | – |
| Q3 2021 | $157,000 | +0.6% | 40,858 | 0.0% | 0.00% | – |
| Q2 2021 | $156,000 | +2128.6% | 40,858 | +1089.1% | 0.00% | – |
| Q3 2020 | $7,000 | – | 3,436 | +1105.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 285 | -98.0% | 0.00% | – |
| Q3 2019 | $49,000 | +4800.0% | 14,382 | +3829.5% | 0.00% | – |
| Q2 2019 | $1,000 | – | 366 | +815.0% | 0.00% | – |
| Q1 2018 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |